Change in treatment paradigm in people who previously injected drugs with chronic hepatitis C in the era of direct-acting antiviral therapy.
Wong, Grace Lai-Hung; Chan, Henry Lik-Yuen; Loo, Ching-Kong; Hui, Yee-Tak; Fung, James Yue-Yan; Cheung, David; Chung, Cedric; Chim, Angel Mei-Ling; Wong, Vincent Wai-Sun.
J Gastroenterol Hepatol
; 34(9): 1641-1647, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-30707777
Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation.
Interferon-based Simeprevir Therapy for Pediatric Patients with Chronic Hepatitis C Viral Infection.
Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C.
Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation.
Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus.
The clinical features and treatment outcome of chronic hepatitis C with pegylated interferon and ribavirin in routine care.
Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C.
Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.
The Safety Profile of Telaprevir-Based Triple Therapy in Clinical Practice: A Retrospective Cohort Study.
Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C.